NCT01411735View on ClinicalTrials.gov

Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

July 31, 2008

Conditions
Heart Failure With Preserved Ejection FractionHeart Failure, Congestive
Interventions
DRUG

Enalapril

2.5mg titrated up to 10mg twice daily

DRUG

placebo

2.5mg titrated up to 10mg twice daily.

All Listed Sponsors
lead

Wake Forest University

OTHER

NCT01411735 - Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure | Biotech Hunter | Biotech Hunter